• BSE
  • NSE
    • {{d.cmpname}}
    • {{d.price}}
    • ({{d.PerChg}}%)
Market | Equity | Daily Market Tracker | IPO Synopsis
IPO SYNOPSIS
Windlas Biotech Ltd
Registered Office:
40/1 Mohabewala Industrial,Area,
Dehradun - 248110,
Uttarakhand, India.
Initial Public Offer of 8,729,023* equity shares of face value of (Rs)5 each ("equity shares") of Windlas Biotech Limited ("company" (Rs)455 per equity share) aggregating to (Rs)401.54 Crores (the "offer") comprising a fresh issue of 3,586,956* equity shares aggregating to (Rs)165 Crores (the "fresh issue") and an offer for sale of 5,142,067* equity shares, comprising of 1,136,000* equity shares aggregating to (Rs)52.26* Crores by Vimla Windlass (the "individual selling shareholder") and 4,006,067* equity shares aggregating to (Rs)184.28* Crores by Tano India Private Equity Fund II (the "investor selling shareholder", and collectively with the individual selling shareholder, the "selling shareholders", and such equity shares, the "offered shares") aggregating to (Rs)236.54 Crores (the "offer for sale). The offer constitutes 40.05% of the post-offer paid-up equity share capital of the Company. The face value of equity shares is (Rs)5 each. The offer price is (Rs)460 per equity share and is 92 times the face value of the equity shares. *subject to finalisation of the basis of allotment.
Issue
Money Payable On
Opens On
Closes On
Application
Allotment
04-Aug-21
06-Aug-21
460.00-0.00
0.00-0.00
Minimum Application for shares in Nos : 30     Further Multiples of : 30
 
(Rs.Cr)
Lead Managers to the Issue
Project Cost
165.00
DAM Capital Advisors Ltd
Project Financed
401.54
 
Post Issue
10.90
 
Issue Price
460.00
 
Projects
Purchase of Equipment required for (i) Capacity Expansion of the existing facility at the Dehradun Plant-IV and (II) Addition of Injectables Dosage Capability at the existing facility at Dehradun Plant - II
Funding Incremental Working Capital Requirements of the Company
Repayment/Prepayment of certain of the Borrowings
General Corporate Purposes
Promoted By
Ashok Kumar Windlass
Hitesh Windlass
Manoj Kumar Windlass
Listing At
BSE
NSE
Registrar to the Issue
Link Intime India Pvt Ltd
DB (International) Stock Brokers Limited: SEBI Reg. No.-INZ000179035 / CDSL : IN-DP-CDSL-266-2004 MCX-SX:INE 260643233/21500(CD)
Daga Commodities Private Limited: SEBI Reg. No. INZ000028833
Investor Grievances Email ID: compliance@dbonline.in & investors@dbonline.in
Copyright © 2016 All rights Reserved DB (International) Stock Brokers Ltd.     Designed, Developed and content powered by C-MOTS Infotech( ISO 9001:2015 certified )
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."         "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors."          "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Attention Investors ::
subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries